HIV and childhood tuberculosis: The way forward

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 5, 2004, Pages 675-682

  Cotton, M F ^a,b   Schaaf, H Simon ^a,b   Hesseling, A C ^a,b   Madhi, S A ^c,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Children; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; EFAVIRENZ; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RITONAVIR; TUBERCULOSTATIC AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; BCG VACCINATION; CHEMOPROPHYLAXIS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DIRECTLY OBSERVED THERAPY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG DOSE REGIMEN; DRUG TOLERABILITY; FEVER; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION SITE; LYMPHADENOPATHY; MALNUTRITION; MORBIDITY; MORTALITY; NUCLEIC ACID AMPLIFICATION; PATIENT COMPLIANCE; PEDIATRICS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; SYSTEMIC DISEASE; THORAX RADIOGRAPHY; TREATMENT PLANNING; TUBERCULIN TEST; TUBERCULOMA; TUBERCULOSIS; VULNERABLE POPULATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 2442573848     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (65)

1. Zumla A, Malon P, Henderson J, Grange J M. Impact of HIV infection, on tuberculosis. Postgrad Med J 2000; 76: 259-268.
2. Chrétien J. Tuberculosis and HIV. The cursed duet. Bull Int Union Tuberc Lung Dis 1990; 65(1): 25-32.
3. Swaminathan S, Nandini K S, Hanna L E, Somu N, Narayanan P R, Barnes P F. T-lymphocyte subpopulations in tuberculosis. Indian Pediatr 2000; 37: 489-495.
4. Martin D J, Sim J G, Sole G J, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 386-391.
5. Zhang Y, Nakata K, Weiden M, Rom W N. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995; 95: 2324-2331.
6. Juffermans N P, Speelman P, Verbon A, et al. Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells. Clin Infect Dis 2001; 32: 650-652.
7. Serbina N V, Lazarevic V, Flynn J L. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol 2001; 167: 6991-7000.
8. Berggren Palme E, Gudeta B, Bruchfeld J, Muhe L, Giesecke H. Impact on human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053-1061.
9. Jeena P M, Pillay P, Pillay T, Coovadia H M. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 2002; 6: 672-678.
10. Lucas S B, Peacock C S, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Côte d'Ivoire. Br Med J 1996; 312: 3354-338.
11. Madhi S A, Huebner R E, Doedens L, Aduc T, Wesley D, Cooper P. HIV co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000; 4: 448-454.
12. Luo C, Chintu C, Bhat G, et al. Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen. Tubercle Lung Dis 1994; 75: 110-115.
13. Mukadi Y D, Wiktor S Z, Coulibaly I M, et al. Impact of HIV infection on the development, clinical presentation, and out-come of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997; 11: 1151-1158.
14. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
15. Miller F J W, Seale R M E, Taylor M D. Tuberculosis in children. Boston, MA: Little Brown, 1963.
16. Coovadia H M, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infection: reconciling conflicting data. Int J Tuberc Lung Dis 1998; 2: 844-851.
17. Kiwanuka J, Graham S M, Coulter J B, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-1 endemic area, Malawi. Ann Trop Paediatr 2001; 21: 5-14.
18. Schaaf H S, Gie R P, Beyers N, Sirgel F A, de Klerk P J, Donald P R. Primary drug resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149-1155.
19. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360: 985-990.
20. Graham S M, Coulter J B, Gilks C F. Pulmonary disease in HIV-infected African children. Int J Tuberc Lung Dis 2001; 5: 12-23.
21. Blusse van Oud-Alblas H J, van Vliet M E, Kimpen J L, de Villiers G S, Schaaf H S, Donald P R. Human immunodeficiency virus infection in children hospitalised with tuberculosis. Ann Trop Paediatr 2002; 22: 15-23.
22. Schaaf H S, Beyers N, Gie R P, et al. Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations. Pediatr Infect Dis J 1995; 14: 189-194.
23. Beyers N, Gie R P, Schaaf H S, et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis 1997; 1: 38-43.
24. Madhi S A, Gray G E, Huebner R E, McKinnon D, Pettifor J M. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in HIV infected and uninfected children with tuberculosis. Pediatr Infect Dis J 1999; 18: 800-805.
25. Adhikari M, Pillay T, Pillay D G. Tuberculosis in the neonate: an emerging disease. Pediatr Infect Dis J 1997; 16: 1018-1022.
26. Hesseling A C, Werschkul H, Westra A, et al. The clinical features and outcome of confirmed tuberculosis in HIV-infected children. Int J Tuberc Lung Dis 2002; 6 (Suppl 1): S181.
27. Houwert K A, Borggreven P A, Schaaf H S, Nel E, Donald P R, Stolk J H. Prospective evaluation of the World Health Organization criteria to assist the diagnosis of tuberculosis in children. Eur Respir J 1998; 11: 1116-1120.
28. Jeena P M, Coovadia H M, Thula S A, Blythe D, Buckels N J, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS 1998; 12: 1185-1193.
29. Jeena P M, Mitha T, Bamber A, Wesley A, Coutsoudis A, Coovadia H M. Effect of human immunodeficiency virus on tuberculosis in children. Tubercle Lung Dis 1996; 77: 437-443.
30. Schaaf H S, Geldenhuys A, Gie R P, Cotton M F. Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 1998; 17: 599-604.
31. Zar H, Hussey G. Finger clubbing in children with human immunodeficiency virus infection. Ann Trop Paediatr 2001; 2: 15-19.
32. Chan S P, Birnbaum J, Rao M, Steiner P. Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1996; 15: 443-447.
33. Moss W J, Dedyo T, Suarez M, Nicholas S D, Abrams E. Tuberculosis in children infected with human immune deficiency virus: a report of 5 cases. Pediatr Infect Dis J 1992; 11: 114-120.
34. Becciolini V, Gudinchet F, Cheseaux J J, Schnyder P. Lymphocytic interstitial pneumonia in children with AIDS: high-resolution CT findings. Eur Radiol 2001; 11: 1015-1020.
35. Hesseling A C, Schaaf H S, Gie R P, Starke J R, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis 2002; 6: 1038-1045.
36. Van Rheenen P. The use of the paediatric tuberculosis score chart in an HIV-endemic area. Trop Med Int Health 2002; 7: 435-441.
37. Jeena P M, Coovadia H M, Hadley L G, Wiersma R, Grant H, Chrystal F V. Lymph node biopsies in HIV infected and non infected children with persistent lung disease. Int J Tuberc Lung Dis 2000; 4: 139-146.
38. Zar H J, Tannenbaum E, Apolles P, Roux P, Hanlso D, Hussey G. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child 2000; 82: 305-308.
39. Schaaf H S, Gie R P, Kennedy M, Beyers N, Hesseling P B, Donald P R. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 2002; 109: 765-771.
40. Kenyon T A, Mwasekaga M J, Huebner R, Rumisha D, Binlein N, Maganu E. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999; 3: 4-11.
41. Fine P E M, Carneiro I A M, Milstien J B, Clements CJ. Issues relating to the use of BCG immunization programmes - a discussion document. Geneva, Switzerland: WHO, 1999.
42. World Health Organization. Expanded programme on immunization: global advisory group. Wkly Epidemiol Rec 1990; 65: 5-11.
43. World Health Organization. Global programme for vaccines and Immunization policy. Geneva, Switzerland: WHO, 1996: 1-51.
44. Talbot E A, Perkins M D, Silva S F, Frothingham R. Disseminated Bacille Calmette-Guerin disease after vaccination: case report and review. Clin Infect Dis 1997; 24: 1139-1146.
45. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376-1395.
46. Hesseling A C, Schaaf H S, Hanekom W A, et al. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children. Clin Infect Dis 2003; 37: 1226-1233.
47. Enarson D A, Rieder H, Arnadottir T, Trebucq A. Management of tuberculosis. A guide for low-income countries. Paris: International Union Against Tuberculosis and Lung Disease, 2000.
48. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with human immunodeficiency virus. N Engl J Med 1997; 337: 801-808.
49. Bucher H C, Griffith L E, Guyatt G H, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 1999; 13: 501-507.
50. Mwinga A, Hosp M, Godfrey-Fausset P, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12: 2447-2457.
51. Schaaf H S, Gie R P, van Rie A, Seifart H I, van Helden P D, Cotton M F. Second episode of tuberculosis in an HIV-infected child: relapse or reinfection? J Infect 2000; 41: 100-103.
52. Driver C R, Munsiff S S, Li J, Kundamal N, Osahan S S. Relapse in persons treated for drug-susceptible tuberculosis in a population with high co-infection with human immunodeficiency virus in New York City. Clin Infect Dis 2000; 33: 1762-1769.
53. Espinal M A, Reingold A L, Perez G, et al. Human immunodeficiency virus infection in children with tuberculosis in Santo Domingo, Dominican Republic: prevalence, clinical findings, and response to antituberculosis treatment. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 155-159.
54. Al Majed S A. Study of paradoxical responses to chemotherapy in tuberculous pleural effusions. Respir Med 1996; 90: 211-214.
55. Chloremis C B C, Padiatellis C, Zoumboulakis D, Yannakos D. Transient exacerbation of fever and roentographic findings during treatment of tuberculosis in children. Am Rev Tuberc 1955; 72: 527-536.
56. Onwubalili J K, Scott G M, Smith J. Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. Quart J Med 1986; 230: 599-610.
57. Rao G P, Nadh B R, Hemaratman A, Srinivas T V, Reddy P K. Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. J Neurosurgery 1995; 83: 359-362.
58. Narito M, Ashkin D, Hollender E S, Pitchenik A E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-161.
59. Frieden T R. Directly observed treatment, short-course (DOTS): ensuring cure of tuberculosis. Indian J Pediatr 2000; 67 (2 Suppl): S21-27.
60. Nair N. Childhood tuberculosis: public health and contact tracing. Paediatr Respir Rev 2001; 2: 97-102.
61. Burman W J, Jones B E. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 2001; 164: 7-12.
62. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064.
63. Hengel R L, Allende M C, Dewar R L, Metcalf J A, Mican J M, Lane H C. Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2002; 18: 969-975.
64. Schluger N W, Perez D, Liu Y M. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 2002; 122: 597-602.
65. Levine L, Bobat R, Cotton M F, Gray G, Meyers T, Violari A. Antiretroviral therapy in children. S Afr J HIV Med 2002; 9: 23-33.